Delivery Order SPE2DX22D0010-SPE2D826FBR30
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a competitively awarded, non-set-aside contract. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $151,220.16 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025, with completion scheduled for September 30, 2025. This firm fixed-price delivery order, awarded without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,960.60 by the Defense Logistics Agency's Medical Supply Chain on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order is a non-competitive award and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,646.92 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $146,793.06 by the Defense Logistics Agency's Medical Supply Chain on December 8, 2025. This competitively awarded, non-set-aside contract carries a firm fixed price structure and is scheduled for completion by December 9, 2025. The delivery order represents a child contract under AmerisourceBergen's significant Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $114,805.60 by the Defense Logistics Agency's Medical Supply Chain on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $10,873.56 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $1,080.31 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025. This firm fixed-price delivery order, which is set to be completed by December 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $102,646.24 on December 2, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of December 3, 2025, was awarded competitively with no set-aside designation. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBR30Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,867.20 by the Defense Logistics Agency's Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 11, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The company serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The delivery order falls within AmerisourceBergen's established role as a pharmaceutical prime vendor for the federal government, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contractor's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This award demonstrates the company's ongoing capability to fulfill federal medical supply requirements through the DLA's flexible contract vehicle, which enables rapid delivery of critical pharmaceutical products to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 12/9/25 |